2013-02-22 13:53:53 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to EMC Instytut Medyczny SA and produced a Rating Update Report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal – SADIF Investment Analytics, announces a new Rating Update Report covering EMC Instytut Medyczny SA (EMC). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential EMC Instytut Medyczny SA investor.
Report Summary: EMC Instytut Medyczny SA is an average quality company with a neutral outlook. EMC Instytut Medyczny SA has strong business growth and is run by passable management. The trend in EMC Instytut Medyczny SA fair value exchange rate against its closest rated-competitor, LZPS Protektor SA, has been depreciating over the past 2 weeks. When compared to its closest competitor, EMC Instytut Medyczny SA shows greater overvaluation and is equally likely to underperform the market.
The 3-page report breaks down
the Total StockMark into its three components – business, management and price, performing an in-depth analysis of EMC Instytut Medyczny SA for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, West Services, Advisen, Alacra-Datadownlink, Factiva, INTERNET SECURITIES and LEXIS/NEXIS or directly from SADIF-Investment Analytics at:
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering sixteen different markets and over 12,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.